GlassScriptPhysician profile
Pavli Samir Demian
NPI 1841622453
$65,225.30
in general payments reported to CMS, 2019-2025
34 companies · $13K in 2025
The $13K reported for 2025 was more than what 98% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,873 · 2020: $1,342 · 2021: $6,115 · 2022: $7,233 · 2023: $14K · 2024: $19K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,385 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,125 · Travel and Lodging: $4,112 · Food and Beverage: $4,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,983.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,385.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,125.00 |
| Travel and Lodging | $4,111.89 |
| Food and Beverage | $4,057.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $58,572.37 | 2019-2025 | Proclaim, Prodigy, Octrode |
| Vertiflex, INC. | $2,558.10 | 2019 | |
| Medtronic USA, INC. | $1,103.96 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $388.30 | 2019-2023 | Ztlido |
| Stryker Corporation | $278.32 | 2025 | Optablate, Mild Device Kit, Spinejack |
| Biodelivery Sciences International, INC. | $275.85 | 2019-2021 | |
| Nuvasive, INC. | $245.89 | 2019-2020 | |
| Boston Scientific Corporation | $235.98 | 2021-2024 | |
| Vertos Medical, INC. | $178.75 | 2022-2024 | Mild Device Kit |
| Tersera Therapeutics LLC | $174.26 | 2019-2022 | |
| Relievant Medsystems, INC. | $143.44 | 2021 | |
| Mml US, INC. | $132.16 | 2024 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $115.85 | 2019-2022 | |
| Si-Bone, INC. | $96.62 | 2019 | |
| Nevro Corp. | $77.63 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $74.42 | 2021-2022 | |
| Nalu Medical, INC. | $72.98 | 2025 | Nalu Neurostimulation System |
| Ferring Pharmaceuticals INC. | $55.09 | 2020-2021 | |
| Horizon Therapeutics Plc | $53.49 | 2021-2022 | |
| Almatica Pharma LLC | $53.39 | 2021 | |
| Bioventus LLC | $51.66 | 2022-2023 | Durolane |
| Kowa Pharmaceuticals America, INC. | $42.27 | 2022 | |
| Grt US Holding, INC. | $29.57 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.12 | 2019 | |
| Pacira Therapeutics, INC. | $27.44 | 2019-2020 | |
| Curonix LLC | $27.34 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ibsa Pharma INC. | $26.82 | 2020-2022 | |
| Sentynl Therapeutics, INC. | $25.64 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.74 | 2021 | |
| Depuy Synthes Sales INC. | $15.39 | 2021 | |
| Pfizer INC. | $13.33 | 2019 | |
| Uswm, LLC | $13.22 | 2021 | |
| Mdd US Operations, LLC | $11.41 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavli Demian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.